WHO in a Big Confusion, Suspends Hydroxychloroquine Solidarity Trial

The World Health Organisation has announced that the hydroxychloroquine arm of the Solidarity Trial is being stopped. 
In a statement on Wednesday, the UN agency said the decision was based on evidence from the Solidarity Trial, UK’s Recovery Trial and a Cochrane review of other evidence on hydroxychloroquine. 
The UN organisation further clarified that the decision “applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre or post-exposure prophylaxis in patients exposed to COVID-19.”
WHO said, “Data from Solidarity (including the French Discovery trail data) and the recently announced results from the UK’s Recovery Trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients when compared with standard of care.”
With this development, investigators will not randomize further patients to hydroxychloroquine in the Solidarity Trial.
“Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician,” WHO stated.


Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN

GARDEN OF EDEN FOUND IN AFRICA

THE HISTORY AND ORIGIN OF THE ZULU PEOPLE

BRIEF HISTORY OF NKALAHA.

FIVE WAYS A WIFE CAN REST HER HUSBAND ON HER

MYSTERY OF IGBO COSMOLOGY

THE ORIGIN AND HISTORY OF UDI by Onyeji Nnaji

ETHIOPIA:THE OLDEST PEOPLE IN THE MIDDLE EAST

KIKUYU, THE SECOND OLDEST BANTU FROM NIGERIA